Coherus BioSciences Inc Net Asset Quality Index
Coherus BioSciences Inc net asset quality index. Coherus BioSciences Inc (CHRS) has a Net Asset Quality Index of 31.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $191.18 Million minus total liabilities of $130.34 Million yields net assets of $60.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Coherus BioSciences Inc net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Coherus BioSciences Inc (2012–2025)
Net asset quality index of Coherus BioSciences Inc from 2012 to 2025. This chart shows how Coherus BioSciences Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 31.8%, representing net assets of $60.84 Million against total assets of $191.18 Million USD. Check strategic asset allocation of Coherus BioSciences Inc to assess the company's strategic physical and investment asset allocation.
Coherus BioSciences Inc Net Asset Quality Index by Year (2012–2025)
Coherus BioSciences Inc net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Coherus BioSciences Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CHRS company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 23.6% | $61.01 Million | $258.34 Million | $197.33 Million | ▲ +53.0 pp |
| 2024 | -29.4% | $-131.99 Million | $448.53 Million | $580.52 Million | ▲ +1.3 pp |
| 2023 | -30.7% | $-193.43 Million | $629.60 Million | $823.03 Million | ▼ -2.1 pp |
| 2022 | -28.6% | $-137.42 Million | $480.85 Million | $618.26 Million | ▼ -43.0 pp |
| 2021 | 14.4% | $97.73 Million | $679.33 Million | $581.61 Million | ▼ -19.0 pp |
| 2020 | 33.4% | $280.97 Million | $841.65 Million | $560.67 Million | ▲ +7.7 pp |
| 2019 | 25.7% | $105.21 Million | $408.93 Million | $303.71 Million | ▲ +64.5 pp |
| 2018 | -38.8% | $-38.59 Million | $99.47 Million | $138.06 Million | ▼ -57.6 pp |
| 2017 | 18.8% | $30.54 Million | $162.61 Million | $132.08 Million | ▲ +7.9 pp |
| 2016 | 10.8% | $19.35 Million | $178.49 Million | $159.13 Million | ▲ +14.1 pp |
| 2015 | -3.3% | $-6.93 Million | $212.38 Million | $219.31 Million | ▼ -38.9 pp |
| 2014 | 35.7% | $66.76 Million | $187.22 Million | $120.46 Million | ▲ +125.0 pp |
| 2013 | -89.3% | $-42.38 Million | $47.45 Million | $89.83 Million | ▼ -124.0 pp |
| 2012 | 34.6% | $9.19 Million | $26.53 Million | $17.34 Million | — |